Cargando…

Advances in cancer research. Volume 97 /

Held at the Karolinska Instituet, in Stockholm, Sweden, a recent Nobel Minisymposium, "Molecular Oncology - From Bench to Bedside," marked a very special event-the celebration of George and Eva Klein's combined 160th birthdays. To honor this occasion, Volume 97 of Advances in Cancer R...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Vande Woude, George F., Klein, George
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Academic Press, 2007.
Colección:Advances in cancer research ; 97
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ma 4500
001 SCIDIR_ocn648303979
003 OCoLC
005 20231117044423.0
006 m o d
007 cr cn|||||||||
008 750720s2007 nyua ob 001 0 eng d
040 |a E7B  |b eng  |e pn  |c E7B  |d OCLCQ  |d OPELS  |d OCLCQ  |d OCLCF  |d OCLCQ  |d DEBBG  |d D6H  |d LEAUB  |d SFB  |d OCLCO  |d OCLCQ  |d OCLCO 
019 |a 1127194018 
020 |a 0120066971  |q (electronic bk.) 
020 |a 9780120066971  |q (electronic bk.) 
020 |z 9780080488202 
020 |a 1281053120 
020 |a 9781281053121 
020 |a 9786611053123 
020 |a 6611053123 
035 |a (OCoLC)648303979  |z (OCoLC)1127194018 
050 4 |a RC267  |b .A483 2007eb 
082 0 4 |a 616.99/40072  |2 22 
245 0 0 |a Advances in cancer research.  |n Volume 97 /  |c edited by George F. Vande Woude, George Klein. 
260 |a New York :  |b Academic Press,  |c 2007. 
300 |a 1 online resource (xvii, 346 pages) :  |b illustrations. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 0 |a Advances in cancer research ;  |v 97 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
520 |a Held at the Karolinska Instituet, in Stockholm, Sweden, a recent Nobel Minisymposium, "Molecular Oncology - From Bench to Bedside," marked a very special event-the celebration of George and Eva Klein's combined 160th birthdays. To honor this occasion, Volume 97 of Advances in Cancer Research brings together a collection of contributions by their former students, colleagues, and collaborators from the past fifty years-dedicated to George and Eva Klein. Over a decade ago, the editors of ACR initiated a subdivision of the series called "Foundations in Cancer Research" to distinguish chapters that reflect extraordinary and historical developments in cancer research- this volume of tributes honoring the Kleins' bodies of work presented at the minisymposium are especially appropriate for the series and should serve as an important resource for future generations. 
505 0 |a Front Cover; Advances in Cancer Research; Copyright Page; Contents; Contributors to Volume 97; Dedication; George Vande Woude; Klas Wiman; Olle Ringdeacuten; Carl-Henrik Heldin and Arne Oumlstman; Alan R. Fersht; Peter H. Krammer; Kenneth Nilsson; Marie Henriksson; Chapter 1: Structural Biology of the Tumor Suppressor p53 and Cancer-Associated Mutants; Abbreviations; I. Introduction; II. The Domain Structure of Human p53; III. The Structure of the DNA-Binding Domain; A. p53C Has Evolved to Be Unstable; B. Design of a Superstable Variant of p53C; C. From Core Domain to the Full-Length Protein 
505 8 |a IV. Effects of Common Cancer MutationsA. Structural Effects of Oncogenic Mutations; V. Rescuing Mutant p53; A. Lessons from Second-Site Suppressor Mutations; B. p53C as a Drug Target; VI. Concluding Remarks; References; Chapter 2: Immunotherapy by Allogeneic Stem Cell Transplantation; I. Introduction; II. Graft-Versus-Host Disease; A. Mechanisms; B. Acute GVHD; C. Chronic GVHD; D. Prevention and Treatment of GVHD; III. The Graft-Versus-Leukemia Effect; A. Preliminary Studies; B. Tumor Burden; C. Enhancement of Graft-Versus-Leukemia; D. Cytotoxic T Cells 
505 8 |a E. Pathophysiology of Graft-Versus-LeukemiaIV. NK Cells; V. Early Detection of Relapse; A. Minimal Residual Disease; B. Mixed Chimerism; C. Molecular Detection of CML; D. Immunoglobulin and T Cell Receptor Gene Rearrangement; VI. The Graft-Versus-Cancer Effect; A. Immunotherapy Against Cancer; B. Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation; C. Reduced Intensity Conditioning and Stem Cell Transplantation for Renal Carcinoma; D. Reduced Intensity Conditioning and Stem Cell Transplantation for Various Solid Tumors 
505 8 |a E. Combined Liver Transplantation and Stem Cell Transplantation for Liver CancerF. Future of Stem Cell Transplantation for Solid Cancers; VII. Mesenchymal Stem Cells; A. Surface Markers and Homing; B. Immunity and Safety of MSCs; C. Immunomodulation by MSC; D. Immunosuppressive Mechanisms by MSCs; VIII. Future Directions; Acknowledgments; References; Chapter 3: Mnt Takes Control as Key Regulator of the Myc/Max/Mxd Network; I. Myc: The Most Frequently Deregulated Oncogene in Human Tumors; A. Myc in Control of Cell Fate; B. Deregulation of Myc in Tumor Development 
505 8 |a C. Myc as a Therapeutic Target for Human CancerII. Mnt: The Key Transcriptional Regulator of the Myc/Max/Mxd Network; A. Discovery and Characterization of Mnt; B. Mnt, the Major Myc Antagonist; C. Effects of Mnt Deficiency; D. Relief of Mnt-Mediated Repression: The Critical Event for Myc Target Gene Activation; E. Mnt to Be or Not to Be a Tumor Suppressor; III. Concluding Remarks; Acknowledgments; References; Chapter 4: Lytic Cycle Switches of Oncogenic Human Gammaherpesviruses; I. Two Life Cycles of EBV and KSHV: Latency and Lytic Replication; II. Virally Encoded Lytic Cycle Activator Genes 
546 |a English. 
650 0 |a Cancer  |x Research. 
650 0 |a Oncology. 
650 2 |a Medical Oncology  |0 (DNLM)D008495 
650 6 |a Cancer  |x Recherche.  |0 (CaQQLa)201-0004697 
650 6 |a Canc�erologie.  |0 (CaQQLa)201-0014055 
650 7 |a Cancer  |x Research  |2 fast  |0 (OCoLC)fst00845497 
650 7 |a Oncology  |2 fast  |0 (OCoLC)fst01045739 
700 1 |a Vande Woude, George F. 
700 1 |a Klein, George. 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780120066971  |z Texto completo